These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 15350333)
21. [Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia]. Toledano Fernández N; García Sáenz S; Díaz Valle D; Arteaga Sánchez A; Segura Bedmar M; Lorenzo Giménez S; Cortés Lambea L Arch Soc Esp Oftalmol; 2003 May; 78(5):265-71. PubMed ID: 12789630 [TBL] [Abstract][Full Text] [Related]
22. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia. Lee JH; Kim YH; Kim MS; Kim EC Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714 [TBL] [Abstract][Full Text] [Related]
23. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Wilson MW; Hungerford JL; George SM; Madreperla SA Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356 [TBL] [Abstract][Full Text] [Related]
24. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Dudney BW; Malecha MA Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170 [TBL] [Abstract][Full Text] [Related]
26. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Sturges A; Butt AL; Lai JE; Chodosh J Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690 [TBL] [Abstract][Full Text] [Related]
27. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Daniell M; Maini R; Tole D Clin Exp Ophthalmol; 2002 Apr; 30(2):94-8. PubMed ID: 11886411 [TBL] [Abstract][Full Text] [Related]
28. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859 [TBL] [Abstract][Full Text] [Related]
29. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769 [TBL] [Abstract][Full Text] [Related]
30. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803 [TBL] [Abstract][Full Text] [Related]
32. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia. Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688 [TBL] [Abstract][Full Text] [Related]
33. Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors. Muñoz de Escalona Rojas JE; García Serrano JL; Cantero Hinojosa J; Padilla Torres JF; Bellido Muñoz RM J Ocul Pharmacol Ther; 2014 Aug; 30(6):489-94. PubMed ID: 24749813 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography. Shousha MA; Karp CL; Perez VL; Hoffmann R; Ventura R; Chang V; Dubovy SR; Wang J Ophthalmology; 2011 Aug; 118(8):1531-7. PubMed ID: 21507486 [TBL] [Abstract][Full Text] [Related]
35. Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia. Huerva V; Mateo AJ; Mangues I; Jurjo C Cornea; 2006 Dec; 25(10):1220-3. PubMed ID: 17172902 [TBL] [Abstract][Full Text] [Related]
36. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Shields CL; Naseripour M; Shields JA Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855 [TBL] [Abstract][Full Text] [Related]
37. The treatment of recurrent conjunctival and corneal intraepithelial neoplasia with interferon alfa-2b and retinoic acid: ~9 years' follow-up on tumor control. Ip MH; Tat L; Coroneo MT Ocul Surf; 2020 Jul; 18(3):354-359. PubMed ID: 32311432 [TBL] [Abstract][Full Text] [Related]
38. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia. Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301 [TBL] [Abstract][Full Text] [Related]
39. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Di Pascuale MA; Espana EM; Tseng SC Cornea; 2004 Jan; 23(1):89-92. PubMed ID: 14701965 [TBL] [Abstract][Full Text] [Related]
40. [Topical interferon alfa-2b or surgical excision for primary treatment of conjunctiva-cornea intraepithelial neoplasia]. Huerva V Arch Soc Esp Oftalmol; 2009 Jan; 84(1):5-6. PubMed ID: 19173133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]